Hormone Therapy May Be OK for Women With Migraines
Title: Hormone Therapy May Be OK for Women With MigrainesCategory: Health NewsCreated: 10/11/2017 12:00:00 AMLast Editorial Review: 10/12/2017 12:00:00 AM (Source: MedicineNet Migraine General)
Source: MedicineNet Migraine General - October 12, 2017 Category: Neurology Source Type: news

Hormone therapy may be OK for women with migraines
Women who suffer from migraines may be able to safely use hormone therapy to treat menopause symptoms, a new study suggests. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 12, 2017 Category: Consumer Health News Source Type: news

Hormone Therapy May Be OK for Women With Migraines
Heightened risk of stroke not borne out in preliminary study (Source: WebMD Health)
Source: WebMD Health - October 11, 2017 Category: Consumer Health News Source Type: news

Hormone Therapy May Be OK for Women With Migraines
WEDNESDAY, Oct. 11, 2017 -- Women who suffer from migraines may be able to safely use hormone therapy to treat menopause symptoms, a new study suggests. The study of 85,000 U.S. women found no evidence that hormone therapy carried a particular risk... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 11, 2017 Category: General Medicine Source Type: news

Despite effectiveness women remain skeptical of hormones at menopause -- what's the problem?
(The North American Menopause Society (NAMS)) Women today have more options than ever before for treating their menopause symptoms, although hormone therapy still ranks as the most effective treatment for debilitating symptoms such as hot flashes. A new study demonstrates, however, that women remain skeptical regarding the safety of hormone therapy and prefer less proven options. The study results will be presented during The North American Menopause Society (NAMS) Annual Meeting in Philadelphia, Oct. 11-14. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - October 11, 2017 Category: International Medicine & Public Health Source Type: news

Health Canada accepts marketing application for Mithra ’s hormone therapy Tibelia
Health Canada has accepted a marketing authorisation application for the Belgian pharmaceutical company Mithra ’s complex therapeutic Tibelia, a tibolone-based product, to be used in hormone therapy (HT). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 10, 2017 Category: Pharmaceuticals Source Type: news

Hormone Therapy and Technology Headline NAMS Meeting Hormone Therapy and Technology Headline NAMS Meeting
The theme of technology will run through the North American Menopause Society (NAMS) meeting, but hormone therapy, breast imaging, lesbian health, and vaginal health are also on the agenda.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 5, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Transgender Hockey Player Postpones Hormone Treatment To Keep Playing
Sports leagues have struggled with how to define gender when it comes to deciding who can play. Pro hockey player Harrison Browne has decided to postpone hormone therapy for one more year on the ice.(Image credit: Courtesy of the National Women's Hockey League) (Source: NPR Health and Science)
Source: NPR Health and Science - September 24, 2017 Category: Consumer Health News Authors: Maggie Mertens Source Type: news

PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) -- This week's topics include hospital factors relevant to readmission, hormone therapy, lymph node dissection in breast cancer, and the cost of bringing a new drug to market (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - September 16, 2017 Category: American Health Source Type: news

Diabetes Drugs' CV Effects; Hormone Therapy; Aneurysms Reduced with T2D?
(MedPage Today) -- Cardiovascular Daily wraps up the top cardiology news of the week (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 15, 2017 Category: Cardiology Source Type: news

Menopause hormone therapy not linked to premature death
According to a study published inJAMA, women who take hormone replacement therapy may be no more likely to die prematurely than women who do not take hormones.Reuters  (Source: Society for Endocrinology)
Source: Society for Endocrinology - September 14, 2017 Category: Endocrinology Source Type: news

Hormone Therapy Isn't As Risky As Once Thought, New Study Finds
Good news for menopausal women. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - September 13, 2017 Category: Consumer Health News Source Type: news

Hormone Therapy Isn't As Risky As Once Thought, New Study Finds
Good news for menopausal women. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - September 13, 2017 Category: Consumer Health News Source Type: news

Could hormone therapy for menopause make a comeback?
New research suggests the hormone therapy won't increase risk of early death (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - September 13, 2017 Category: Consumer Health News Source Type: news

Diabetes Targets Hard to Meet in Transgender Population
(MedPage Today) -- Hormone therapy tied to increased modi?able risks (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - September 13, 2017 Category: Primary Care Source Type: news

Hormone therapy does not increase risk of cancer
Harvard Medical School did a follow-up on a 90s study that claimed hormone therapy caused risk of heart disease, cancers and premature death. It showed the risks were not caused by the drug. (Source: the Mail online | Health)
Source: the Mail online | Health - September 13, 2017 Category: Consumer Health News Source Type: news

Up to 7 years of hormone therapy is safe for postmenopausal women, new data show
For decades now, women navigating menopause have been buffeted by shifting research findings on the risks and possible benefits of hormone-replacement therapy. Now, a landmark clinical trial that followed more than 27,000 subjects for roughly 18 years has offered some conclusive evidence that neither... (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - September 12, 2017 Category: Science Authors: Melissa Healy Source Type: news

Menopausal Hormone Therapy Not Associated with Mortality Risk (FREE)
By Amy Orciari Herman Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM Menopausal hormone therapy does not put women at increased risk for death, according to long-term follow-up from the Women's Health … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 12, 2017 Category: Primary Care Source Type: news

Menopause hormone therapy not linked to premature death
(Reuters Health) - Women who take hormone replacement therapy (HRT) to ease menopause symptoms like hot flashes and night sweats may be no more likely to die prematurely than women who don ’t take hormones, a new study suggests. (Source: Reuters: Health)
Source: Reuters: Health - September 12, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Hormone therapy does notincrease risk of cancer
Harvard Medical School did a follow-up on a 90s study that claimed hormone therapy caused risk of heart disease, cancers and premature death. It showed the risks were not caused by the drug. (Source: the Mail online | Health)
Source: the Mail online | Health - September 12, 2017 Category: Consumer Health News Source Type: news

Why Hormone Replacement Therapy May Be Safer Than You Think
The pendulum has swung from one extreme to the other when it comes to hormone replacement therapy (HRT) to treat symptoms of menopause. At first, the replacement hormones—mostly a combination of estrogen and progestin to replace what the body stops making after menopause—were seen as a panacea. Doctors thought they could not only relieve hot flashes and night sweats, but also prevent chronic aging diseases like heart problems and weakening bones. But studies then found that the supplement hormones could lead to a higher risk of breast cancer—and that they didn’t protect the heart after all. In the l...
Source: TIME.com: Top Science and Health Stories - September 12, 2017 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Drugs estrogen Hormone Therapy hormones for menopause hot flashes night sweats progestin Reproductive Health treating menopause Source Type: news

Hormone Therapy: No Excess Mortality in 18-Year WHI Follow-up Hormone Therapy: No Excess Mortality in 18-Year WHI Follow-up
Cardiovascular mortality, total cancer mortality, and all-cause mortality all remained statistically similar among women who did and did not use hormone therapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 12, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Menopausal Hormone Therapy: Why Mortality Outcomes Are ‘ Vital ’ Menopausal Hormone Therapy: Why Mortality Outcomes Are ‘ Vital ’
Dr JoAnn Manson is the lead author of a new report that examined all-cause and cause-specific mortality among women who have taken hormone replacement therapy for menopausal symptoms.Medscape Ob/Gyn (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 12, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Commentary Source Type: news

Menopausal hormone therapy not associated with mortality or deaths from CVD
(Brigham and Women's Hospital) In the overall study of women ages 50-79, researchers found no increase or decrease in total mortality or deaths from cardiovascular disease, cancer or other major illnesses in the randomized hormone therapy trials. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 12, 2017 Category: Cancer & Oncology Source Type: news

Managing Pain Can Be a Puzzle After Breast Cancer
Women who take opioids are more likely to stop vital hormonal therapy, study finds (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 11, 2017 Category: Cancer & Oncology Tags: Endocrinology, Oncology, Pharmacy, News, Source Type: news

Managing Pain Can Be a Puzzle After Breast Cancer
Women who take opioids are more likely to stop vital hormonal therapy, study finds Source: HealthDay Related MedlinePlus Pages: Breast Cancer, Pain Relievers, Seniors' Health (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - September 11, 2017 Category: Consumer Health News Source Type: news

Managing Pain Can Be a Puzzle After Breast Cancer
Women who take opioids are more likely to stop vital hormonal therapy, study finds (Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - September 11, 2017 Category: Cancer & Oncology Source Type: news

Patients with high risk prostate cancer may benefit 'equally' from two new treatments
(European Society for Medical Oncology) Patients with high risk prostate cancer starting long-term hormone therapy may benefit from two new treatments, according to late-breaking results from the STAMPEDE trial presented at the ESMO 2017 Congress in Madrid. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 8, 2017 Category: International Medicine & Public Health Source Type: news

Hormone therapy improves cardiac structure in growth hormone deficiency
According to a study, published in theJournal of Clinical Endocrinology& Metabolism, children that received growth hormone therapy for one year experienced improvements in cardiac structure, body composition and cardiopulmonary functional capacity.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - September 4, 2017 Category: Endocrinology Source Type: news

Hormone therapy improves sleep quality for menopausal women
A new study, published inMenopause, has found that low-dose hormone therapy may be effective in easing sleep issues in early menopausal women. EurekAlert (Source: Society for Endocrinology)
Source: Society for Endocrinology - September 1, 2017 Category: Endocrinology Source Type: news

Options Available for Estrogen Depletion After Breast Cancer
Women should be encouraged to optimize lifestyle and should not be treated with hormone therapy (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 30, 2017 Category: Cancer & Oncology Tags: Endocrinology, Family Medicine, Gynecology, Internal Medicine, Nursing, Oncology, Pharmacy, Psychiatry, Urology, Journal, Source Type: news

Study finds hormone therapy improves sleep quality for recently menopausal women
(Mayo Clinic) A new study published in Menopause: The Journal of The North American Menopause Society has found that low-dose hormone therapy may be effective in easing sleep issues in this population. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 29, 2017 Category: International Medicine & Public Health Source Type: news

Imaging The Effects Of Menopausal Hormone Therapy On The Brain
By Kejal Kantarci, MD, MS, Mayo Clinic-Rochester, Society for Women’s Health Research Interdisciplinary Network on Alzheimer’s (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - August 24, 2017 Category: Consumer Health News Source Type: news

Endocrine Specialist Nurse
Type: 18 hours per week (flexible)Location: Home or based in our Bristol office, with occasional nationwide travel.Salary: £32,000 -£36,000 pro-rataWe are looking for an Endocrine Specialist Nurse, with experience predominantly in pituitary disease, to join our charity’s Patient and Family Services Team. You will be responsible for delivering our telephone Endocrine Nurse Helpline Service.  This post will be for 18 hours per week, with some flexibility and will include three or more Helpline sessions. The Nurse is the clinical lead amongst our staff team and is part ...
Source: Society for Endocrinology - August 24, 2017 Category: Endocrinology Source Type: news

Study documents continued decline in use of hormone therapy by Canadian women
(The North American Menopause Society (NAMS)) Ever since menopause was first discussed publicly, the debate over the use of hormone therapy (HT) has monopolized headlines. Recognized as the most effective option for managing hot flashes and other menopause symptoms, the use of HT has continued to decline, largely as a result of the data released from the Women's Health Initiative (WHI) in 2002. New study results published in Menopause, documents the decline, along with the factors affecting a Canadian woman's likelihood of using HT. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 22, 2017 Category: International Medicine & Public Health Source Type: news

NAMS' New Hormone Therapy Position Statement: Clinical Takeaways NAMS' New Hormone Therapy Position Statement: Clinical Takeaways
Who can safely take hormone therapy and for how long? Are there alternatives? Dr JoAnn Manson answers questions based on the new position statement from the North American Menopause Society.Medscape Internal Medicine (Source: Medscape ObGyn and Womens Health Headlines)
Source: Medscape ObGyn and Womens Health Headlines - August 16, 2017 Category: OBGYN Tags: Internal Medicine Commentary Source Type: news

NAMS' Hormone Therapy Statement: Primary Care Takeaways NAMS' Hormone Therapy Statement: Primary Care Takeaways
Who can safely take hormone therapy and for how long? Are there alternatives? Dr JoAnn Manson answers questions based on the new position statement from the North American Menopause Society.Medscape Internal Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 15, 2017 Category: Consumer Health News Tags: Internal Medicine Commentary Source Type: news

Risk of CV Mortality vs Benefit of Hormonal Therapy in PCa Risk of CV Mortality vs Benefit of Hormonal Therapy in PCa
Do men with cardiac risk factors benefit when given hormonal therapy for prostate cancer?Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 10, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Fear of Interactions May Affect Adherence in HIV+ Trans Women Fear of Interactions May Affect Adherence in HIV+ Trans Women
A study found that fear of interactions between hormone therapy and antiretroviral therapy may hinder medication adherence in transgender women with HIV; more research is needed on tailoring care to this group.Medscape Medical News (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - August 7, 2017 Category: Infectious Diseases Tags: Diabetes & Endocrinology News Source Type: news

Research Needed to Assess CV Risks of Transgender Hormone Therapy Research Needed to Assess CV Risks of Transgender Hormone Therapy
An evidence review stresses that longer-term, larger studies are needed into the long-term effects of hormone therapy on CVD outcomes in transgender individuals.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 1, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

In assessing risk of hormone therapy for menopause, dose — not form — matters
FINDINGSWhen it comes to assessing the risk of estrogen therapy for menopause, how the therapy is delivered — taking a pill versus wearing a patch on one’s skin — doesn’t affect risk or benefit, researchers at UCLA and elsewhere have found. But with the commonly used conjugated equine estrogen, plus progestogen, the dosage does. Higher doses, especially over time, are associated with greater risk of problems, including heart disease and some types of cancer, especially among obese women.BACKGROUNDThe Women ’s Health Initiative established the potential of estrogen therapy to increase or decrea...
Source: UCLA Newsroom: Health Sciences - July 27, 2017 Category: Universities & Medical Training Source Type: news

Hormone therapy for transgender adults poses potential heart risks
Long-term cross-sex hormone therapy for transgender individuals is associated with potential cardiovascular risks but psychological benefits, according to a review published inAnnals of Internal Medicine.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - July 26, 2017 Category: Endocrinology Source Type: news

New ASCO Guideline on Second-Line Hormone Therapy in Prostate Cancer
The American Society of Clinical Oncology (ASCO) issued the first guidance, a provisional clinical opinion (PCO), on second-line hormonal therapy for chemotherapy-naive castration-resistant prostate cancer (CRPC). Today we are speaking about the guideline with one of its authors, Eric Singer, MD, a urologic oncologist at Rutgers Cancer Institute of New Jersey. —Interviewed by Anna Azvolinsky (Source: CancerNetwork)
Source: CancerNetwork - July 26, 2017 Category: Cancer & Oncology Authors: Eric Singer, MD Tags: Genitourinary Cancers Q & Prostate Cancer Source Type: news

In assessing risk of hormone therapy for menopause, dose -- not form -- matters
(University of California - Los Angeles Health Sciences) UCLA-led research finds that the way estrogen therapy for menopause is delivered doesn't affect risk or benefit. What DOES make a difference with the commonly used conjugated equine estrogen, plus progestogen, is dosage. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 26, 2017 Category: Cancer & Oncology Source Type: news

Hormone Tx tied to cardiovascular risk in transgender adults
A review inAnnals of Internal Medicineassociates cross-sex hormone therapy with increased cardiovascular risk factors among transgender men (female to male), especially among those on testosterone treatment.MedPage Today (Source: Society for Endocrinology)
Source: Society for Endocrinology - July 25, 2017 Category: Endocrinology Source Type: news

Drug interaction concerns may affect HIV treatment adherence among transgender women
(NIH/National Institute of Allergy and Infectious Diseases) Transgender women -- at high risk of HIV acquisition -- are a key population for HIV prevention and treatment efforts. A study supported by NIH and Gilead Sciences reveals that more than half of transgender living with HIV in Los Angeles were concerned that taking both antiretroviral therapy to treat HIV and feminizing hormone therapy (HT) may cause harmful drug-drug interactions. Many surveyed cited these concerns as a reason for not taking anti-HIV medications, HT, or both. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 24, 2017 Category: International Medicine & Public Health Source Type: news

Additional studies needed to evaluate CVD risks of hormone therapy for transgender patients
(Brigham and Women's Hospital) Additional studies needed to evaluate cardiovascular disease risks of long-term, hormone therapy for transgender patients (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 24, 2017 Category: International Medicine & Public Health Source Type: news

Updated position on hormone therapy for menopause
Andrew Kaunitz, professor in the Department of Obstetrics and Gynecology at the University of Florida College of Medicine, discusses new guidance from the North American Menopause Society on hormone therapy.Medscape (Source: Society for Endocrinology)
Source: Society for Endocrinology - July 18, 2017 Category: Endocrinology Source Type: news